Vaccine delivery systems toward lymph nodes

被引:128
作者
Ding, Yingyue [1 ,2 ]
Li, Zhaoting [1 ,2 ]
Jaklenec, Ana [3 ]
Hu, Quanyin [1 ,2 ]
机构
[1] Univ Wisconsin, Sch Pharm, Pharmaceut Sci Div, Madison, WI 53705 USA
[2] Univ Wisconsin, Carbone Canc Ctr, Sch Med & Publ Hlth, Madison, WI 53705 USA
[3] MIT, Koch Inst Integrat Canc Res, Cambridge, MA 02142 USA
关键词
Vaccine; Lymph nodes; Delivery barriers; Targeted delivery; Lymphocytes; Immune response; DENDRITIC CELLS; IMMUNE-RESPONSES; COVID-19; VACCINE; PHASE-II; IMMUNIZATION PRACTICES; NANOPARTICLES TARGET; CHECKPOINT BLOCKADE; ADVISORY-COMMITTEE; NEXT-GENERATION; CONDUIT SYSTEM;
D O I
10.1016/j.addr.2021.113914
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Strategies of improving vaccine targeting ability toward lymph nodes have been attracting considerable interest in recent years, though there are remaining delivery barriers based on the inherent properties of lymphatic systems and limited administration routes of vaccination. Recently, emerging vaccine delivery systems using various materials as carriers are widely developed to achieve efficient lymph node targeting and improve vaccine-triggered adaptive immune response. In this review, to further optimize the vaccine targeting ability for future research, the design principles of lymph node targeting vaccine delivery based on the anatomy of lymph nodes and vaccine administration routes are first summarized. Then different designs of lymph node targeting vaccine delivery systems, including vaccine delivery systems in clinical applications, are carefully surveyed. Also, the challenges and opportunities of current delivery systems for vaccines are concluded in the end. (C) 2021 Elsevier B.V. All rights reserved.
引用
收藏
页数:22
相关论文
共 224 条
[1]   Lymphatic targeting by albumin-hitchhiking: Applications and optimisation [J].
Abdallah, Mohammad ;
Mullertz, Olivia O. ;
Styles, Ian K. ;
Morsdorf, Alexander ;
Quinn, John F. ;
Whittaker, Michael R. ;
Trevaskis, Natalie L. .
JOURNAL OF CONTROLLED RELEASE, 2020, 327 :117-128
[2]   Lipid Nanoparticles as Delivery Systems for RNA-Based Vaccines [J].
Aldosari, Basmah N. ;
Alfagih, Iman M. ;
Almurshedi, Alanood S. .
PHARMACEUTICS, 2021, 13 (02) :1-29
[3]   Liposomal drug delivery systems: From concept to clinical applications [J].
Allen, Theresa M. ;
Cullis, Pieter R. .
ADVANCED DRUG DELIVERY REVIEWS, 2013, 65 (01) :36-48
[4]   MRI-traceable theranostic nanoparticles for targeted cancer treatment [J].
Anani, Tareq ;
Rahmati, Shiva ;
Sultana, Nayer ;
David, Allan E. .
THERANOSTICS, 2021, 11 (02) :579-601
[5]   Dendritic Cells as Pharmacological Tools for Cancer Immunotherapy [J].
Anguille, Sebastien ;
Smits, Evelien L. ;
Bryant, Christian ;
Van Acker, Heleen H. ;
Goossens, Herman ;
Lion, Eva ;
Fromm, Phillip D. ;
Hart, Derek N. ;
Van Tendeloo, Viggo F. ;
Berneman, Zwi N. .
PHARMACOLOGICAL REVIEWS, 2015, 67 (04) :731-753
[6]   Clinical use of dendritic cells for cancer therapy [J].
Anguille, Sebastien ;
Smits, Evelien L. ;
Lion, Eva ;
van Tendeloo, Viggo F. ;
Berneman, Zwi N. .
LANCET ONCOLOGY, 2014, 15 (07) :E257-E267
[7]  
[Anonymous], [No title captured]
[8]  
Avigan DE, 2020, BIOL BLOOD MARROW TR, V26, pS62
[9]   Targeted Delivery of Immunomodulators to Lymph Nodes [J].
Azzi, Jamil ;
Yin, Qian ;
Uehara, Mayuko ;
Ohori, Shunsuke ;
Tang, Li ;
Cai, Kaimin ;
Ichimura, Takaharu ;
McGrath, Martina ;
Maarouf, Omar ;
Kefaloyianni, Eirini ;
Loughhead, Scott ;
Petr, Jarolim ;
Sun, Qidi ;
Kwon, Mincheol ;
Tullius, Stefan ;
von Andrian, Ulrich H. ;
Cheng, Jianjun ;
Abdi, Reza .
CELL REPORTS, 2016, 15 (06) :1202-1213
[10]   Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns [J].
Bachmann, Martin F. ;
Jennings, Gary T. .
NATURE REVIEWS IMMUNOLOGY, 2010, 10 (11) :787-796